Navigation Links
Jennerex Announces First Patient Treated in Phase 2 Clinical Trial of Intravenous Delivery JX-594 In Patients with Advanced Liver Cancer
Date:7/25/2012

SAN FRANCISCO, July 25, 2012 /PRNewswire/ -- Jennerex, Inc., a private, clinical-stage biotherapeutics company focused on the development and commercialization of first-in-class targeted oncolytic immunotherapies, today announced that the first patient has been treated in a Phase 2 clinical trial of intravenous treatment with JX-594 for patients with advanced hepatocellular carcinoma (HCC), or liver cancer, who have not received treatment with sorafenib—the current standard of care for this patient population.  This trial expands the development of the JX-594 program in HCC, which is currently being evaluated in a multi-national Phase 2b trial (TRAVERSE) in patients with advanced HCC who have failed prior sorafenib.

This Phase 2 trial is a multinational, single-arm, open-label study of JX-594 administered weekly by intravenous infusions in sorafenib-naive patients with advanced HCC. The primary objective of the study is to determine the radiographic response rate based on modified RECIST and modified Choi criteria.  Patients will subsequently be followed for progression-free survival and overall survival. The trial is being conducted at sites in South Korea, the United States, and Europe.  For more information about this trial as well as the Phase 2b TRAVERSE trial, please visit www.clinicaltrials.gov.

"We are pleased to have treated our first patient in this study, which will build on our experience with intravenous treatment with JX-594 and will allow us to assess anti-tumor activity of multiple intravenous infusions in the liver cancer patients specifically," said David H. Kirn, M.D., founder, chief medical officer and president of research and development.  "Unlike other treatments in the class, JX-594 can be administered intravenously, and we've shown that it has the ability to target tumors systemically—in addition to locally—and, therefore, has the
'/>"/>

SOURCE Jennerex, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Jennerex Appoints Dr. Laurent Fischer as President and Chief Executive Officer
2. Precision Optics Corporation Announces $1 Million Order for Microprecision™ Based Endoscopes
3. Young Innovations, Inc. Announces Record Sales and EPS for the Quarter Ended March 31, 2012
4. JDRF Announces Research Collaboration with Dexcom, Inc. to Develop "Smart Transmitter" Technology to Accelerate Artificial Pancreas Studies
5. Misonix Announces New Distribution Agreement For Panama
6. University of Maryland BioPark Announces MedImmunes Dr. Bahija Jallal as Newest Member of Board of Directors for UM Health Sciences Research Park
7. Novelos Therapeutics Announces Successful Completion of First Cohort In Lung Cancer Trial With I-124-CLR1404 (LIGHT) Cancer-Targeted PET Imaging Agent at UW Carbone Cancer Center
8. Boston Scientific Announces CE Mark and European Launch of Emerge™ PTCA Dilatation Catheter
9. Soligenix Announces Further Progress with ThermoVax™ for Long-Term Vaccine ThermoStability
10. Masimo Announces New Low-Profile Infant and Neonatal Pulse Oximetry Sensors
11. Anthera Announces the Completion of Patient Dosing in Phase 2b PEARL-SC Study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/2/2015)... , March 2, 2015   Polymedco is committed to ...  During CRC Awareness Month, we are offering all existing ... , Posters – to be hung in ... CRC Patient Brochures with Stand – to be placed ... – to be put on/in patient charts as a ...
(Date:3/2/2015)... 2015  Kush Bottles, North America,s ... for the marijuana industry, announced today that its CEO ... nominated for a 2015 Excellence in Entrepreneurship Award.  ... is designed to recognize individuals who exemplify the ... creativity and determination, have established and nurtured successful ...
(Date:3/2/2015)... , March 2, 2015 Attorney ... investigating potential claims on behalf of purchasers of ... or the "Company") (NasdaqGM: VTAE -News).  Such investors ... or his investor relations coordinator Eitan Kimelman ... The investigation concerns whether Vitae Pharmaceuticals and ...
Breaking Medicine Technology:Polymedco CDP, LLC. Promotes March as Colorectal Cancer Awareness Month 2Kush Bottles CEO, Nicholas Kovacevich, Nominated for 2015 "Excellence in Entrepreneurship Award" 2SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Vitae Pharmaceuticals, Inc. 2
... BRIDGEWATER, N.J., April 18, 2011 Sanofi-aventis ... today that it has entered into a multi-year research ... supports, organizes, and facilitates interdisciplinary, collaborative and innovative research ... collaboration was signed today by Dr. Paul Chew, Senior ...
... Diagnostics, Inc., a privately-held Minnesota corporation, and Vertical Health ... a reverse merger.  Pursuant to the merger agreement, OnPoint ... (VHS) and shall constitute the sole business and operations ... and executive team of OnPoint will become the board ...
Cached Medicine Technology:Sanofi-aventis Enters into Collaboration Agreement with Stanford University Bio-X to Focus on Early-Stage Scientific Research 2Sanofi-aventis Enters into Collaboration Agreement with Stanford University Bio-X to Focus on Early-Stage Scientific Research 3OnPoint Medical Diagnostics, Inc. and Vertical Health Solutions, Inc. Complete Reverse Merger 2OnPoint Medical Diagnostics, Inc. and Vertical Health Solutions, Inc. Complete Reverse Merger 3
(Date:3/2/2015)... March 02, 2015 Getting customers to ... is the goal this March as the 31st annual ... by the National Frozen & Refrigerated Foods Association (NFRA) ... Ian’s offers more than 20 delicious frozen selections and ... , The tasty frozen options are crafted with simple ...
(Date:3/2/2015)... Cutler Integrative Medicine a leader in bringing innovative naturopathic ... to bring about self-renewal. A 30 day detox is ... cleaning house. According to Dr. Cutler, expert in ... environmental toxins like heavy metals, people’s food now becoming ... levels, we all have a level of toxic burden. ...
(Date:3/2/2015)... York, NY (PRWEB) March 02, 2015 ... long history of catalyzing private sector activities and ... it has recently elected four new members to ... GBCHealth welcomes Dr. Paul Farmer, Chief Strategist and ... Professor at Harvard University; Dr. Huma Abbasi, General ...
(Date:3/2/2015)... 2015 Just months after the ... the use of power morcellators ( http://www.morcellatorlawsuit2015.com ) ... insurer UnitedHealthCare is poised to restrict coverage for ... In a notification sent to physicians in January, ... would require pre-authorization for laparoscopic or abdominal hysterectomies, ...
(Date:3/2/2015)... Raleigh, NC (PRWEB) March 02, 2015 ... response can be a better predictor of outcomes for ... here to read details of the new study ... and pathologists at the University of Eastern Piedmont followed ... underwent talc pleurodesis treatment for excess lung fluid. ...
Breaking Medicine News(10 mins):Health News:Take a Fresh Look at Frozen with Ian’s 2Health News:Skin and Wellness Power Couple give Quick Tips to Self-Renewal for Spring 2Health News:Dr. Paul Farmer and Leaders from Chevron, Johnson & Johnson and Merck Join GBCHealth’s Board of Directors 2Health News:Dr. Paul Farmer and Leaders from Chevron, Johnson & Johnson and Merck Join GBCHealth’s Board of Directors 3Health News:Dr. Paul Farmer and Leaders from Chevron, Johnson & Johnson and Merck Join GBCHealth’s Board of Directors 4Health News:Dr. Paul Farmer and Leaders from Chevron, Johnson & Johnson and Merck Join GBCHealth’s Board of Directors 5Health News:Power Morcellator Lawyers at Bernstein Liebhard LLP Comment on Insurers’ Decision to Restrict Most Common Form of Hysterectomies 2Health News:Power Morcellator Lawyers at Bernstein Liebhard LLP Comment on Insurers’ Decision to Restrict Most Common Form of Hysterectomies 3Health News:Power Morcellator Lawyers at Bernstein Liebhard LLP Comment on Insurers’ Decision to Restrict Most Common Form of Hysterectomies 4Health News:New Research Links Talc Treatment Response with Mesothelioma Prognosis, According to Surviving Mesothelioma 2
... surged to their highest level this year and remain at ... ministry figures showed 432 people were infected last week, the ... exceeded the ministry's "epidemic threshold" of 378 cases per week. ... the ministry and the National Environment Agency said in a ...
... the benefits of taking an ice bath after exercise but ... is the secret of her success . ,Many Physiotherapists ... soreness after exercise and to to speed up recovery. They ... theory is that the icy cold causes the blood vessels ...
... Norway has shown that there have been substantial savings ... requiring doctors to prescribe the recommended first-line treatment ... 2004, family doctors have been reimbursed for drug costs ... uncomplicated hypertension, unless there are medical reasons for selecting ...
... is our inability to understand the exponential function." ... Colorado ,From time immemorial, the human male ... animal kingdom, too, is no exception to this power equation. ... planet has lived to regret! ,In ...
... July issue of the journal Cancer Cell, published by ... the potency and effectiveness of a tumor necrosis factor ... cancers. , A new study identifies a ... a promising treatment currently being used in clinical trials. ...
... the Chinese soldier is immaculate -- backed by sturdy cardboard ... and even his height. ,Next to it, propped ... Park, are two photographs, one showing the 28-year-old bachelor proudly ... his smartly dressed father watches as dozens of other parents ...
Cached Medicine News:Health News:Ice Bath by Sports Star Questioned 2Health News:Reduction in Drug Costs 2Health News:MEN as Partners to MEND Maternal Health A World Population Day Initiative 2Health News:MEN as Partners to MEND Maternal Health A World Population Day Initiative 3Health News:New Cancer Therapy in Clinical Trial 2Health News:Parental Match-making Blossoms in a Beijing Park 2Health News:Parental Match-making Blossoms in a Beijing Park 3
... testing simplified In-office. Information. In real time. The ... indications of elevated vaginal fluid pH (pH >= ... innovative format is easy to use and delivers ... Simply rub a swab containing unprocessed vaginal fluid ...
For the quantitative determination of human MMP-9/NGAL Complex concentrations in cell culture supernates, serum,plasma, urine and saliva....
... the increase in Endoscopic cases, it is extremely ... with the Surgical Light. This combination affords ... having to adopt an uncomfortable pose. The ... the NUVO Monitoring System. As such the ...
... of your procedural specialty, whether it ... NUVO Monitoring System will complement the ... ergonomics and advanced high-resolution display technology. ... mobile carts, the NUVO Monitor provides ...
Medicine Products: